Gill Lawrence

6.6k total citations
58 papers, 2.1k citations indexed

About

Gill Lawrence is a scholar working on Oncology, Cancer Research and Pathology and Forensic Medicine. According to data from OpenAlex, Gill Lawrence has authored 58 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Oncology, 26 papers in Cancer Research and 15 papers in Pathology and Forensic Medicine. Recurrent topics in Gill Lawrence's work include Global Cancer Incidence and Screening (44 papers), Breast Cancer Treatment Studies (25 papers) and Colorectal Cancer Screening and Detection (16 papers). Gill Lawrence is often cited by papers focused on Global Cancer Incidence and Screening (44 papers), Breast Cancer Treatment Studies (25 papers) and Colorectal Cancer Screening and Detection (16 papers). Gill Lawrence collaborates with scholars based in United Kingdom, Australia and Netherlands. Gill Lawrence's co-authors include Olive Kearins, Matthew Wallis, Jem Rashbass, Nancy Tappenden, Marco Zappa, Elisabete Weiderpass, Henrik Møller, Maja Primic Žakelj, Matti Hakama and Freddie Bray and has published in prestigious journals such as Journal of the American Chemical Society, JNCI Journal of the National Cancer Institute and Cancer.

In The Last Decade

Gill Lawrence

57 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gill Lawrence United Kingdom 22 1.1k 939 452 414 386 58 2.1k
Stefano Ferretti Italy 27 1.1k 1.0× 377 0.4× 481 1.1× 310 0.7× 244 0.6× 110 2.1k
Richard J. Bleicher United States 26 1.6k 1.4× 1.2k 1.2× 507 1.1× 535 1.3× 226 0.6× 112 3.0k
Ida Ackerman Canada 23 452 0.4× 730 0.8× 288 0.6× 493 1.2× 372 1.0× 39 2.0k
Anne Eaton United States 29 899 0.8× 931 1.0× 555 1.2× 781 1.9× 131 0.3× 92 2.2k
Nina Horowitz United States 16 627 0.6× 674 0.7× 345 0.8× 295 0.7× 132 0.3× 50 1.4k
Elizabeth H. Wood United States 6 1.1k 0.9× 303 0.3× 258 0.6× 495 1.2× 211 0.5× 21 2.2k
Lucìa Mangone Italy 22 1.3k 1.1× 373 0.4× 318 0.7× 289 0.7× 211 0.5× 96 2.1k
D. Hölzel Germany 30 2.0k 1.8× 671 0.7× 276 0.6× 905 2.2× 258 0.7× 126 3.2k
B. Cutuli France 27 1.1k 1.0× 1.4k 1.5× 945 2.1× 389 0.9× 123 0.3× 91 2.9k
Wendy Shelley Canada 19 789 0.7× 1.3k 1.4× 586 1.3× 462 1.1× 91 0.2× 25 2.2k

Countries citing papers authored by Gill Lawrence

Since Specialization
Citations

This map shows the geographic impact of Gill Lawrence's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gill Lawrence with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gill Lawrence more than expected).

Fields of papers citing papers by Gill Lawrence

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gill Lawrence. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gill Lawrence. The network helps show where Gill Lawrence may publish in the future.

Co-authorship network of co-authors of Gill Lawrence

This figure shows the co-authorship network connecting the top 25 collaborators of Gill Lawrence. A scholar is included among the top collaborators of Gill Lawrence based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gill Lawrence. Gill Lawrence is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kelly, Nicole L., Gill Lawrence, Paul Wheatley, et al.. (2025). Exploiting in situ NMR spectroscopy to understand non-traditional methods for zeolite synthesis. Chemical Science. 16(10). 4245–4255. 2 indexed citations
2.
Ettlinger, Romy, Morven J. Duncan, Gill Lawrence, et al.. (2025). In Situ Single-Crystal X-ray Diffraction Studies of an Anomalous Nitric Oxide Adsorption in a Partially Activated Metal–Organic Framework. Journal of the American Chemical Society. 147(34). 31260–31269. 1 indexed citations
3.
Maxwell, Anthony, Karen Clements, Bridget Hilton, et al.. (2018). Risk factors for the development of invasive cancer in unresected ductal carcinoma in situ. European Journal of Surgical Oncology. 44(4). 429–435. 66 indexed citations
4.
Woods, Laura M., Bernard Rachet, Dianne L. O’Connell, Gill Lawrence, & Michel P. Coleman. (2016). Impact of deprivation on breast cancer survival among women eligible for mammographic screening in the West Midlands (UK) and New South Wales (Australia): Women diagnosed 1997–2006. International Journal of Cancer. 138(10). 2396–2403. 17 indexed citations
5.
Mauguen, Audrey, Bernard Rachet, Simone Mathoulin‐Pélissier, et al.. (2015). Validation of death prediction after breast cancer relapses using joint models. BMC Medical Research Methodology. 15(1). 27–27. 6 indexed citations
6.
Rafia, Rachid, Alan Brennan, Jason Madan, et al.. (2015). Modeling the Cost-Effectiveness of Alternative Upper Age Limits for Breast Cancer Screening in England and Wales. Value in Health. 19(4). 404–412. 14 indexed citations
7.
Thomas, Jeremy, Andrew M. Hanby, Sarah E. Pinder, et al.. (2014). Adverse surgical outcomes in screen-detected ductal carcinoma in situ of the breast. European Journal of Cancer. 50(11). 1880–1890. 12 indexed citations
8.
Bates, T, T. Evans, Catherine Lagord, et al.. (2014). A population based study of variations in operation rates for breast cancer, of comorbidity and prognosis at diagnosis: Failure to operate for early breast cancer in older women. European Journal of Surgical Oncology. 40(10). 1230–1236. 23 indexed citations
9.
Bundred, Nigel, Julie Morris, W.F. Knox, et al.. (2011). Are symptomatic guidelines for chemotherapy appropriate to ER-positive screen-detected breast cancer (SDBC)?. Breast Cancer Research and Treatment. 138(2). 359–368. 3 indexed citations
10.
Allgood, P C, S W Duffy, Olive Kearins, et al.. (2011). Explaining the difference in prognosis between screen-detected and symptomatic breast cancers. British Journal of Cancer. 104(11). 1680–1685. 62 indexed citations
11.
Wishart, Gordon, Elizabeth M. Azzato, David Greenberg, et al.. (2010). PREDICT: a new UK prognostic model that predicts survival following surgery for invasive breast cancer. Breast Cancer Research. 12(1). R1–R1. 283 indexed citations
12.
Nagtegaal, Irıs D., P C Allgood, Stephen W. Duffy, et al.. (2010). Prognosis and pathology of screen‐detected carcinomas. Cancer. 117(7). 1360–1368. 45 indexed citations
13.
Maxwell, Anthony, Andy Evans, R Carpenter, et al.. (2009). Follow-up for screen-detected ductal carcinoma in situ: Results of a survey of UK centres participating in the Sloane project. European Journal of Surgical Oncology. 35(10). 1055–1059. 4 indexed citations
14.
Woods, Laura M., Bernard Rachet, Dianne L. O’Connell, et al.. (2008). Large differences in patterns of breast cancer survival between Australia and England: A comparative study using cancer registry data. International Journal of Cancer. 124(10). 2391–2399. 16 indexed citations
15.
Thomas, Jeremy, Andrew M. Hanby, Sarah E. Pinder, et al.. (2008). Implications of Inconsistent Measurement of ER Status in Non-Invasive Breast Cancer: A Study of 1,684 Cases from the Sloane Project. The Breast Journal. 14(1). 33–38. 15 indexed citations
16.
Clare, Joseph, et al.. (2008). The use of cervical screening history data to interpret cervical cancer incidence trends. Journal of Public Health. 30(2). 171–177. 5 indexed citations
17.
Wallis, Matthew, et al.. (2008). Non-operative diagnosis—effect on repeat-operation rates in the UK breast screening programme. European Radiology. 19(2). 318–323. 7 indexed citations
18.
Duffy, Stephen W., Irıs D. Nagtegaal, Matthew Wallis, et al.. (2008). Correcting for Lead Time and Length Bias in Estimating the Effect of Screen Detection on Cancer Survival. American Journal of Epidemiology. 168(1). 98–104. 182 indexed citations
19.
Kellen, Eliane, Maurice P. Zeegers, Miranda J.M. Dirx, et al.. (2007). Occurrence of both bladder and prostate cancer in five cancer registries in Belgium, The Netherlands and the United Kingdom. European Journal of Cancer. 43(11). 1694–1700. 29 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stefano Ferretti Breakdown of academic impact, for papers by Richard J. Bleicher Breakdown of academic impact, for papers by Ida Ackerman Breakdown of academic impact, for papers by Anne Eaton Breakdown of academic impact, for papers by Nina Horowitz Breakdown of academic impact, for papers by Elizabeth H. Wood Breakdown of academic impact, for papers by Lucìa Mangone Breakdown of academic impact, for papers by D. Hölzel Breakdown of academic impact, for papers by B. Cutuli Breakdown of academic impact, for papers by Wendy Shelley
Rankless by CCL
2026